Chronic infection and severe mitral regurgitation: first of all, do not harm

Int J Cardiovasc Imaging. 2024 Dec;40(12):2635-2639. doi: 10.1007/s10554-024-03267-9. Epub 2024 Oct 26.

Abstract

techniques of mitral valve repair has improved in the last decades. Percutaneous approach is now a reliable and safe therapy in those patients with high surgical risk. However, the presence of an implanted prothesis increases the risk of endocarditis. we describe a case of a 75-year-old man with medical history of recurrent cellulitis due to chronic lymphedema, who had percutaneous edge-to-edge mitral valve treatment. After three months he developed fever without any specific symptoms. Emocolture were positive for Staphilococcus lugdunensis. Transesophageal echocardiogram demonstrated a huge vegetation at the level of Edwards Pascal device. Patients was then referred to cardiac surgery for mitral valve replacement with bioprothesis. in patients needing a prothesis implantation the management and treatment of chronic infection is of paramount importance to reduce the risk of prothesis infection procedure. Endocarditis after percutaneous edge-to-edge mitral valve treatment represents a rare but a life-threatening condition.

Keywords: Chronic infection; Echocardiogram; Endocraditis; Mitral valve.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Bioprosthesis
  • Chronic Disease
  • Echocardiography, Transesophageal*
  • Endocarditis, Bacterial* / complications
  • Endocarditis, Bacterial* / diagnosis
  • Endocarditis, Bacterial* / diagnostic imaging
  • Endocarditis, Bacterial* / microbiology
  • Endocarditis, Bacterial* / surgery
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Heart Valve Prosthesis Implantation* / instrumentation
  • Heart Valve Prosthesis*
  • Humans
  • Male
  • Mitral Valve Insufficiency* / diagnostic imaging
  • Mitral Valve Insufficiency* / physiopathology
  • Mitral Valve Insufficiency* / surgery
  • Mitral Valve* / diagnostic imaging
  • Mitral Valve* / microbiology
  • Mitral Valve* / physiopathology
  • Mitral Valve* / surgery
  • Prosthesis Design
  • Prosthesis-Related Infections* / diagnostic imaging
  • Prosthesis-Related Infections* / microbiology
  • Prosthesis-Related Infections* / surgery
  • Risk Factors
  • Severity of Illness Index
  • Staphylococcal Infections* / diagnosis
  • Staphylococcal Infections* / diagnostic imaging
  • Staphylococcal Infections* / microbiology
  • Staphylococcal Infections* / surgery
  • Staphylococcal Infections* / therapy
  • Staphylococcus lugdunensis / isolation & purification
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents